Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp DNDPF


Primary Symbol: T.DC.A Alternate Symbol(s):  DDEJF | T.DC.P.B | DNDEF | T.DC.P.D

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Comment by Macpooron Jun 07, 2023 8:52pm
110 Views
Post# 35485601

RE:RE:RE:RE:TauRx Article in The Scotsman

RE:RE:RE:RE:TauRx Article in The Scotsman

TauRx plans to submit HMTM for regulatory approval in the US and Canada in 2023, with other territories to follow, in line with its overall plans to commercialise HMTM and pursue clinical trials in other related neurodegenerative diseases.
<< Previous
Bullboard Posts
Next >>